A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus
Clinical trial NCT04963296 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04963296
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-26
- Primary completion
- 2025-09-15
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.